Adult T-cell leukaemia/lymphoma-like human T-cell leukaemia virus-1 replication in infective dermatitis

British Journal of Haematology

Volumn 123, Issue 3, 2003, Pages 406-412

  Gabet, Anne Sophie ^a   Kazanji, Mirdad ^b   Couppie, Pierre ^b   Clity, Emmanuel ^b   Pouliquen, Jean François ^b   Sainte Marie, Dominique ^b   Aznar, Christine ^b   Wattel, Eric ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Human T cell leukaemia virus 1 (HTLV 1); Infective dermatitis; Leukaemia; Lymphoma; Virus

Indexed keywords

COTRIMOXAZOLE; IVERMECTIN; LAMIVUDINE;

ARTICLE; CANCER SUSCEPTIBILITY; CASE REPORT; CONTROLLED STUDY; DERMATITIS; DNA FLANKING REGION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTIVE DERMATITIS; INFESTATION; LYMPHOCYTE CLONE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; STRONGYLOIDIASIS; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL DIVISION; CHILD; CLONE CELLS; DERMATITIS; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LAMIVUDINE; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; PARASITIC DISEASES; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; T-LYMPHOCYTES; VIRAL LOAD; VIRUS REPLICATION;

EID: 0242361138     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04565.x     Document Type: Article

References (26)

1. Agape, P., Copin, M.C., Cavrois, M., Panelatti, G., Plumelle, Y., Ossondo-Landeau, M., Quist, D., Grossat, N., Gosselin, B., Fenaux, P. & Wattel, E. (1999) Implication of HTLV-1 infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies). Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 20, 394-402.
2. Balestrieri, E., Forte, G., Matteucci, C., Mastino, A. & Macchi, B. (2002) Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro. Antimicrobial Agents in Chemotherapy, 46, 3080-3083.
3. Cavrois, M., Gessain, A., Wain-Hobson, S. & Wattel, E. (1996a) Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene, 12, 2419-2423.
4. Cavrois, M., Wain-Hobson, S., Gessain, A., Plumelle, Y. & Wattel, E. (1996b) Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. Blood, 88, 4646-4650.
5. Cavrois, M., Leclercq, I., Gout, O., Gessain, A., Wain-Hobson, S. & Wattel, E. (1998) Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene, 17, 77-82.
6. Gabet, A.S., Mortreux, F., Talarmin, A., Plumelle, Y., Leclercq, I., Leroy, A., Gessain, A., Clity, E., Joubert, M. & Wattel, E. (2000) High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis (in process citation). Oncogene, 19, 4954-4960.
7. Garcia-Lerma, J.G., Nidtha, S. & Heneine, W. (2001) Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine. Journal of Infectious Diseases, 184, 507-510.
8. Gessain, A., Barin, F., Vernant, J.C., Gout, O., Maurs, L., Calender, A. & de The, G. (1985) Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet, 2, 407-410.
9. Goncalves, D.U., Guedes, A.C., Carneiro-Proietti, A.B. & Lambertucci, J.R. (2000) HTLV-1 associated infective dermatitis may be an indolent HTLV-1 associated lymphoma. Brazilian Journal of Infectious Diseases, 4, 100-102.
10. Hanchard, B., LaGrenade, L., Carberry, C., Fletcher, V., Williams, E., Cranston, B., Blattner, W.A. & Manns, A. (1991) Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years. Lancet, 338, 1593-1594.
11. La Grenade, L. (1996) HTLV-1-associated infective dermatitis: past, present, and future. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 13, S46-S49.
12. LaGrenade, L., Hanchard, B., Fletcher, V., Cranston, B. & Blattner, W. (1990) Infective dermatitis of Jamaican children: a marker for HTLV-1 infection. Lancet, 336, 1345-1347.
13. La Grenade, L., Manns, A., Fletcher, V., Derm, D., Carberry, C., Hanchard, B., Maloney, E.M., Cranston, B., Williams, N.P., Wilks, R., Kang, B.C. & Blattner, W.A. (1998) Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type 1-associated infective dermatitis in children. Archives of Dermatology, 134, 439-444.
14. Machuca, A. & Soriano, V. (2000) In vivo fluctuation of HTLV-1 and HTLV-11 proviral load in patients receiving antiretroviral drugs. Journal of Acquired Immune Deficiency Syndrome, 24, 189-193.
15. Machuca, A., Rodes, B. & Soriano, V. (2001) The effect of antiretroviral therapy on HTLV infection. Virus Research, 78, 93-100.
16. Mahaney, Jr, F.X. (1991) Infective dermatitis linked to HTLV-1. Journal of the National Cancer Institute, 83, 240-241.
17. Mortreux, F., Leclercq. I., Gabet, A., Leroy, A., Westhof, E., Gessain, A., Wain-Hobson, S. & Wattel, E. (2001) Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. Journal of the National Cancer Institute, 93, 367-377.
18. Mortreux, F., Gabet, A.S. & Wattel, E. (2003) Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia, 17, 26-38.
19. Nakada, K., Yamaguchi, K., Furugen, S., Nakasone, T., Nakasone, K., Oshiro, Y., Kohakura, M., Hinuma, Y., Seiki, M., Yoshida, M., Matutes, E., Catovsky, D., Ishii, T. & Takatsuky, K. (1987) Monoclonal integration of HTLV-1 proviral DNA in patients with strongyloidiasis. International Journal of Cancer, 40, 145-148.
20. Plumelle, Y., Gonin, C., Edouard, A., Bucher, B.J., Thomas, L. Brebion, A. & Panelatti, G. (1997) Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. American Journal of Clinical Pathology, 107, 81-87.
21. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D. & Gallo, R.C. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences of the USA, 77, 7415-7421.
22. Satoh, M., Toma, H., Sugahara, K., Etoh, K., Shiroma, Y., Kiyuna, S., Takara, M., Matsuoka, M., Yamaguchi, K., Nakada, K., Fujita, K., Kojima, S., Hori, E., Tanaka, Y., Kamihira, S., Sato, Y. & Watanabe, T. (2002) Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+) 25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis. Oncogene, 21, 2466-2475.
23. Taylor, G.P., Hall, S.E., Navarrete, S., Michie, C.A., Davis, R., Witkover, A.D., Rossor, M., Nowak, M.A., Rudge, P., Matutes, E., Bangham, C.R. & Weber, J.N. (1999) Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. Journal of Virology, 73, 10289-10295.
24. Tschachler, E. & Franchini, G. (1998) Infective dermatitis: a pabulum for human T-lymphotrophic virus type 1 leukemogenesis? Archives of Dermatology, 134, 487-488.
25. Tsukasaki, K., Yamada, Y., Ikeda, S. & Tomonaga, M. (1994) Infective dermatitis among patients with ATL in Japan. International Journal of Cancer, 57, 293.
26. Yamaguchi, K., Matutes, E., Catovsky, D., Galton, D.A., Nakada, K. & Takatsuki, K. (1987) Strongyloides stercoralis as candidate co-factor for HTLV-1-induced leukaemogenesis (letter). Lancet, 2, 94-95.